Cystic fibrosis is autosomal recessive. That means a child must inherit two copies of a mutated gene, one from each biological parent, to develop the disease. A single mutated copy makes someone a carrier but does not cause symptoms.
How Recessive Inheritance Works
Every person carries two copies of the CFTR gene. In a dominant condition, one faulty copy is enough to cause disease. Cystic fibrosis works differently. The body can produce enough functional protein from just one working copy of the gene, so carriers typically have no symptoms at all and may never know they carry the mutation.
Problems arise when both parents are carriers. Each pregnancy between two carriers has a 25% chance of producing a child with cystic fibrosis, a 50% chance of producing another carrier, and a 25% chance of producing a child with no mutations at all. These odds reset with every pregnancy. Having one child with CF does not change the probability for the next.
What the CFTR Gene Actually Does
The CFTR gene tells the body how to build a protein that works as a chloride channel on the surface of cells. This channel moves chloride ions in and out of cells that produce mucus, sweat, saliva, tears, and digestive enzymes. That flow of chloride controls how water moves through tissues, which keeps mucus thin and slippery.
When both copies of the gene are mutated, the chloride channel either doesn’t form correctly, doesn’t reach the cell surface, or breaks down too quickly. Without proper chloride and water transport, the mucus lining the lungs, pancreas, and other organs becomes abnormally thick and sticky. That thick mucus traps bacteria in the airways, blocks digestive enzymes from reaching the intestines, and gradually damages organs over time. More than 1,000 different mutations in the CFTR gene have been identified in people with CF, though a single mutation called F508del accounts for a large share of cases worldwide.
How Common Are Carriers?
Carrier rates vary by ethnic background. Among white Americans, roughly 1 in 29 people carries a CFTR mutation. Among African Americans, the rate is about 1 in 65. Many carriers have no family history of CF and no reason to suspect they carry the gene. Because two carriers can have children who appear perfectly healthy (the 75% of outcomes that don’t produce CF), the mutation can pass silently through families for generations before two carriers happen to have a child together.
Carrier screening is available before or during pregnancy. Options include ethnicity-based screening, which targets mutations more common in specific populations, and expanded panels that test for many genetic conditions at once. Testing can be done as early as 10 weeks into a pregnancy to determine whether a fetus has CF or is a carrier.
How CF Is Diagnosed in Newborns
All 50 U.S. states include cystic fibrosis in their newborn screening programs. A positive newborn screen doesn’t confirm CF on its own. It flags babies who need a follow-up sweat test, which measures how much chloride is in their sweat. A sweat chloride level of 60 mmol/L or higher confirms a CF diagnosis. Levels below 30 mmol/L mean CF is unlikely. Results between 30 and 59 fall into an intermediate range that requires further genetic testing to sort out.
For newborns who screen positive, the sweat test is typically performed after 10 days of age, once the baby weighs more than about 4.4 pounds. Doctors often begin CF-related care before a definitive diagnosis is finalized, since early treatment makes a meaningful difference in outcomes.
What This Means for Life Expectancy
Cystic fibrosis was once considered a childhood disease with very short survival. That has changed dramatically. According to Cystic Fibrosis Foundation data from 2024, children born with CF between 2020 and 2024 are predicted to live to age 65 or beyond. That improvement comes from better infection management, earlier diagnosis through newborn screening, and a newer class of medications called modulators that target the defective protein itself rather than just managing symptoms. For families receiving a CF diagnosis today, the outlook is fundamentally different from what it was even 15 years ago.
Inheritance Scenarios at a Glance
- Both parents are carriers: 25% chance the child has CF, 50% chance the child is a carrier, 25% chance the child inherits no mutations.
- One parent is a carrier, one is not: No chance the child has CF. 50% chance the child is a carrier.
- One parent has CF, the other is not a carrier: Every child will be a carrier, but none will have CF.
- One parent has CF, the other is a carrier: 50% chance the child has CF, 50% chance the child is a carrier.